Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
VRTX
Stock Latest News
Weekend Updates
Skechers, Shopify, Diamondback, Vertex, Turtle Beach: Trending by Analysts
9h ago
SKX
FANG
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2d ago
BOLT
HRTX
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3d ago
MRK
ATHE
Premium
Market News
LLY, VRTX, or ABBV: Which Healthcare Stock Is the Best Pick?
3d ago
LLY
ABBV
Premium
The Fly
Beam Therapeutics price target lowered to $55 from $78 at Guggenheim
3d ago
BEAM
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Hold Rating Amid Revenue Misses, Pipeline Challenges, and Slow Product Transitions
3d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals price target raised to $499 from $467 at Barclays
3d ago
VRTX
Premium
The Fly
Wolfe downgrades Vertex Pharmaceuticals on slow pain launch
3d ago
VRTX
Premium
Company Announcements
Vertex Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
4d ago
VRTX
Premium
The Fly
Vertex downgraded to Peer Perform from Outperform at Wolfe Research
4d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals price target raised to $621 from $617 at Goldman Sachs
4d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $442 from $450 at Scotiabank
4d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals price target raised to $464 from $462 at Morgan Stanley
4d ago
VRTX
Premium
Ratings
Optimistic Outlook for Vertex Pharmaceuticals Driven by Strong Market Penetration and Strategic Clinical Advancements
4d ago
VRTX
Premium
Ratings
Cautious Hold Rating for Vertex Pharmaceuticals Amid Mixed Performance and Future Challenges
4d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals price target raised to $423 from $420 at RBC Capital
4d ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Strong Growth Prospects and Strategic Positioning Support Buy Rating Despite Q1 Miss
4d ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Hold Rating Amid Revenue Misses and Strategic Outlook
4d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
4d ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Strong Market Performance and Promising Future Prospects Reinforce Buy Rating
4d ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Strong Fundamentals and Promising Future Despite Short-term Challenges
4d ago
VRTX
Premium
Company Announcements
Vertex Pharmaceuticals Reports Strong Q1 2025 Performance
5d ago
VRTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
